This post was originally published on this site
<p xmlns="https://www.w3.org/1999/xhtml"><span class="xn-location">DUBLIN, <span class="xn-chron">Jan. 18, 2021 /PRNewswire/ — The "Filgrastim Biosimilars Global Market Opportunities and Strategies to 2030: COVID-19 Implications and Growth" report has been added to <b>ResearchAndMarkets.com's</b> offering. <br xmlns="https://www.w3.
Recommended articles
Pomerantz Law Firm Announces the Filing of a Class Action against Voyager Therapeutics, Inc. and Certain Officers – VYGRNEW YORK, Jan. 23, 2021 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Voyager Therapeutics, Inc. ("Voyager" or the "Company") (NASDAQ: VYGR) and certain of...(read more)
Jericho Expands Energy Portfolio with Agreement for the Acquisition of Hydrogen TechnologyTULSA, Okla. and VANCOUVER, British Columbia, Jan. 22, 2021 (GLOBE NEWSWIRE) -- Jericho Oil Corporation (“Jericho”) (TSX-V: JCO; OTC PINK: JROOF) is pleased to announce that it is has entered into an...(read more)
The University of Arizona Global Campus and MzeroA Announce PartnershipSAN DIEGO, Jan. 22, 2021 /PRNewswire/ -- The University of Arizona Global Campus (UAGC) has announced a new academic partnership with in-flight training provider MzeroA that will offer students the op...(read more)
ROSEN, LEADING INVESTOR COUNSEL, Files First Securities Class Action Lawsuit Against Lizhi Inc.; Encourages Investors with Losses Exceeding $100K to Contact Firm – LIZINEW YORK, Jan. 22, 2021 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, announces it has filed a class action lawsuit on behalf of purchasers of the securities of Lizhi Inc. (NASDAQ...(read more)
Bastion Balance Seoul, Korea.